Highlights from ASCO 2011

While there weren’t new blockbuster announcements for colorectal cancer this year at the American Society for Clinical Oncology’s (ASCO) Annual Meeting, there was plenty of focus on making what we already have work better and on choosing the patients who will benefit the most from treatments, as well as those who might not be helped at…  Read More

Out of Pocket Costs Limiting Cancer Patient Treatment Choices

Twelve percent of people with advanced colorectal cancer spent more than $25,000 of their own money for cancer treatment, according to a new survey done by Thomson Reuters. The study also found that one in eight late-stage cancer patients had turned down recommended treatment because of costs.  Among patients with incomes less than $40,000 a year,…  Read More